Skip to content

13F-HR filed by CAXTON CORP

CAXTON CORP filed this 13F-HR for the quarter ended 2023-06-30, filed 2023-08-14, with 7 holding rows worth $34,653,386.

Accession
0000919574-23-004721
Filed
2023-08-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2023

A holdings report, 7 entries on the cover page, a total value of $34,653,386 stated on the cover page (in dollars after the unit check, H1), rows summing to $34,653,386 with VALUE read as dollars as filed, 13F file number 028-15293. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
SAVARA INC805111101COM4,980,804$16,026,005dollars as filedThe filing omitted confidential holdings, a later amendment may add them.
XERIS BIOPHARMA HOLDINGS INC98422E103COM5,641,920$14,781,830dollars as filedThe filing omitted confidential holdings, a later amendment may add them.
REZOLUTE INC76200L309COMMON STOCK1,318,967$2,611,555dollars as filedThe filing omitted confidential holdings, a later amendment may add them.
MOLECULAR TEMPLATES INC608550109COM2,052,991$985,436dollars as filedThe filing omitted confidential holdings, a later amendment may add them.
COMPASS THERAPEUTICS INC20454B104COM43,466$138,220dollars as filedThe filing omitted confidential holdings, a later amendment may add them.
ALLAKOS INC01671P100COM17,733$77,318dollars as filedThe filing omitted confidential holdings, a later amendment may add them.
ELEVATION ONCOLOGY INC COM28623U101Stock21,725$33,022dollars as filedThe filing omitted confidential holdings, a later amendment may add them.

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000919574-23-004721this filing2023-08-14acceptance time not in the bulk data set